WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009135842) AZETIDINES AND CYCLOBUTANES AS HISTAMINE H3 RECEPTOR ANTAGONISTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/135842    International Application No.:    PCT/EP2009/055418
Publication Date: 12.11.2009 International Filing Date: 05.05.2009
IPC:
C07D 205/04 (2006.01), C07D 401/12 (2006.01), C07D 403/12 (2006.01), C07D 401/06 (2006.01), A61K 31/397 (2006.01), A61K 31/496 (2006.01), A61P 25/00 (2006.01), C07D 403/14 (2006.01), C07D 471/04 (2006.01), C07D 487/04 (2006.01), A61P 1/00 (2006.01), A61P 9/00 (2006.01), A61P 11/00 (2006.01)
Applicants: EVOTEC AG [DE/DE]; Schnackenburgallee 114 22525 Hamburg (DE) (For All Designated States Except US).
DAVENPORT, Adam James [GB/GB]; (GB) (For US Only).
HALLETT, David James [GB/GB]; (GB) (For US Only).
CORSI, Massimo [IT/IT]; (IT) (For US Only)
Inventors: DAVENPORT, Adam James; (GB).
HALLETT, David James; (GB).
CORSI, Massimo; (IT)
Agent: BÜCHEL, Edwin; Isenbruck Bösl Hörschler LLP Eastsite One Seckenheimer Landstrasse 4 68163 Mannheim (DE)
Priority Data:
08155915.5 08.05.2008 EP
61/139,461 19.12.2008 US
Title (EN) AZETIDINES AND CYCLOBUTANES AS HISTAMINE H3 RECEPTOR ANTAGONISTS
(FR) AZÉTIDINES ET CYCLOBUTANES COMME ANTAGONISTES DES RÉCEPTEURS H3 DE L'HISTAMINE
Abstract: front page image
(EN)The invention relates to compounds of formula (I) wherein R, R0, R1, m, n and X1 to X4 have the meaning as cited in the description and the claims. Said compounds are useful as Histamine H3 receptor antagonists. The invention also relates to pharmaceutical compositions, the preparation of such compounds as well as the production and use as medicament.
(FR)La présente invention concerne des composés de formule (I) dans laquelle R, R0, R1, m, n et X1 à X4 ont la signification donnée dans la description et les revendications. Lesdits composés sont utiles comme antagonistes des récepteurs H3 de l'histamine. L'invention concerne également des compositions pharmaceutiques, la préparation de tels composés ainsi que leur production et leur utilisation comme médicament.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)